All Stories

  1. Lead replacement due to non-infectious reasons in patients undergoing traditional cardiac resynchronization therapy in long-term follow-up
  2. Quality of life in patients with a leadless pacemaker versus transvenous pacemaker
  3. Echocardiographic imaging in patients with conduction system pacing
  4. Right atrial and dual chamber leadless pacemaker implantation: A pioneer experience in Poland. Findings from a multicentre national registry — a preliminary report
  5. Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence
  6. The impact of shock therapy on depression development and remote prognosis in cardiac resynchronization therapy recipients
  7. Left bundle branch area pacing in children: case series
  8. Long-term outcome, mortality predictors and cardiac-device related infective endocarditis in patients with surgically corrected valvular versus non-valvular heart failure treated with cardiac resynchronization therapy
  9. Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures
  10. Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts
  11. Single-chamber leadless pacemaker Aveir VR implantation: Pioneer experience in Poland. Insights and preliminary report from a multicenter national registry
  12. Management of patients with an electrical storm or clustered ventricular arrhythmias: a clinical consensus statement of the European Heart Rhythm Association of the ESC—endorsed by the Asia-Pacific Heart Rhythm Society, Heart Rhythm Society, and Latin-...
  13. Predictors of ventricular tachyarrhythmia in patients with implantable cardioverter-defibrillator and non-ischemic systolic heart failure
  14. Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments
  15. Lead-related tricuspid regurgitation and ventricle dysfunction: Current management and future perspectives
  16. Linee guida ESC 2022 per la valutazione cardiovascolare e la gestione dei pazienti sottoposti a chirurgia non cardiaca elaborate dalla task force per la valutazione cardiovascolare e la gestione dei pazienti sottoposti a chirurgia non cardiaca della So...
  17. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey
  18. Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP‐AF general long‐term registry
  19. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
  20. Contemporary management of ventricular electrical storm in Europe: results of a European Heart Rhythm Association Survey
  21. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
  22. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
  23. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
  24. Practical considerations, indications, and future perspectives for leadless and extravascular cardiac implantable electronic devices: a position paper by EHRA/HRS/LAHRS/APHRS
  25. Quality of life in patients with a subcutaneous vs. transvenous implantable cardioverter-defibrillator
  26. Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke
  27. EHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices
  28. Utilization of Subcutaneous Cardioverter-Defibrillator in Poland and Europe–Comparison of the Results of Multi-Center Registries
  29. Importance of Dedicated Units for the Management of Patients With Inherited Arrhythmia Syndromes
  30. Upgrade from implantable cardioverter-defibrillator vs. de novo implantation of cardiac resynchronization therapy: long-term outcomes
  31. Utilization and perception of same-day discharge in electrophysiological procedures and device implantations: an EHRA survey
  32. Patient perspective and safety of remote monitoring of implantable cardioverter-defibrillators in the Polish Nationwide Multicenter Registry: the Medtronic CareLink network evaluation
  33. Diagnosis, family screening, and treatment of inherited arrhythmogenic diseases in Europe: results of the European Heart Rhythm Association Survey
  34. Vascular disease in patients with atrial fibrillation. A report from Polish participants in the EORP‐AF General Long‐Term Registry
  35. Quality indicators for the care and outcomes of adults with atrial fibrillation
  36. Mobile health applications for managing atrial fibrillation for healthcare professionals and patients: a systematic review
  37. Cohort profile: the ESC EURObservational Research Programme Atrial Fibrillation III (AF III) Registry
  38. Successful implantation of leadless pacemakers in children: a case series
  39. Peri-procedural management, implantation feasibility, and short-term outcomes in patients undergoing implantation of leadless pacemakers: European Snapshot Survey
  40. Trends in antithrombotic management in patients with atrial fibrillation: a report from Polish participants in the EURObservational Research Programme – Atrial Fibrillation General Long-Term Registry
  41. Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based...
  42. Factors influencing the use of leadless or transvenous pacemakers: results of the European Heart Rhythm Association Prospective Survey
  43. Diagnosis and management of left atrial appendage thrombus in patients with atrial fibrillation undergoing cardioversion or percutaneous left atrial procedures: results of the European Heart Rhythm Association survey
  44. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
  45. Antithrombotic treatment in patients with atrial fibrillation and acute coronary syndromes: results of the European Heart Rhythm Association survey
  46. The influence of age on the psychological profile of patients with cardiac implantable electronic devices: results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association
  47. Prevention of sudden cardiac death by the implantable cardioverter-defibrillator
  48. Risk stratification for complex ventricular arrhythmia complicating ST-segment elevation myocardial infarction
  49. Factors determining the choice between subcutaneous or transvenous implantable cardioverter-defibrillators in Poland in comparison with other European countries: a sub-study of the European Heart Rhythm Association prospective survey
  50. Outcomes in patients undergoing cardiac resynchronisation therapy complicated by device-related infective endocarditis
  51. European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), C...
  52. Translating guidelines into practice for the management of atrial fibrillation: results of an European Heart Rhythm Association Survey
  53. Management of patients with ventricular arrhythmias and prevention of sudden cardiac death—translating guidelines into practice: results of the European Heart Rhythm Association survey
  54. Left ventricular scar and the acute hemodynamic effects of multivein and multipolar pacing in cardiac resynchronization
  55. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantati...
  56. Prognostic Significance of Complex Ventricular Arrhythmias Complicating ST-Segment Elevation Myocardial Infarction
  57. Cryoballoon ablation of atrial fibrillation in patients with advanced systolic heart failure and cardiac implantable electronic devices
  58. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey
  59. Ventricular fibrillation induced by a radiofrequency energy delivery for premature ventricular contractions arising from the right ventricular outflow tract – is ICD indicated?
  60. Use of leadless pacemakers in Europe: results of the European Heart Rhythm Association survey
  61. Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients
  62. Patients’ knowledge and attitudes regarding living with implantable electronic devices: results of a multicentre, multinational patient survey conducted by the European Heart Rhythm Association
  63. Management of ventricular tachycardia in the ablation era: results of the European Heart Rhythm Association Survey
  64. Long-term outcome of catheter ablation and other form of therapy for electrical storm in patients with implantable cardioverter-defibrillators
  65. Approach to cardio-oncologic patients with special focus on patients with cardiac implantable electronic devices planned for radiotherapy: results of the European Heart Rhythm Association survey
  66. Significance of Atrial Fibrillation Complicating ST-Segment Elevation Myocardial Infarction
  67. Catheter Ablation of Atrial Fibrillation: An Overview for Clinicians
  68. The Changing Landscape for Stroke Prevention in AF
  69. Cryoablation for treatment of cardiac arrhythmias: results of the European Heart Rhythm Association survey
  70. Device-related infective endocarditis in cardiac resynchronization therapy recipients — Single center registry with over 2500 person-years follow up
  71. Gender-related differences in long-term outcome among high-risk patients with myocardial infarction treated invasively
  72. The Incidence, Clinical Significance, and Treatment Effects of Depression in Cardiac Resynchronization Therapy Recipients
  73. Ultra-fast, high-density 3D mapping system for catheter ablation of infrequent, “unmappable” idiopathic ventricular arrhythmia – a case report.
  74. Automatyczny kardiowerter-defibrylator u chorych z nieischemiczną niewydolnością serca – czy wyniki badania Danish Trial są szokiem?
  75. Do we need to monitor the percentage of biventricular pacing day by day?
  76. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey
  77. The Impact of Routine Angiographic Follow-Up in a Population of Patients Undergoing Percutaneous Coronary Intervention Within the Left Main Coronary Artery
  78. Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population
  79. In Heart Failure Patients with Left Bundle Branch Block Single Lead MultiSpot Left Ventricular Pacing Does Not Improve Acute Hemodynamic Response To Conventional Biventricular Pacing. A Multicenter Prospective, Interventional, Non-Randomized Study
  80. Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot)
  81. LV mechanical dispersion as a predictor of ventricular arrhythmia in patients with advanced systolic heart failure
  82. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience
  83. The use of wearable cardioverter-defibrillators in Europe: results of the European Heart Rhythm Association survey
  84. Management of atrial fibrillation in patients with chronic kidney disease in Europe Results of the European Heart Rhythm Association Survey
  85. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  86. Liczba i wskaźniki objętości płytek krwi u chorych z wywołanym kontrastem ostrym uszkodzeniem nerek i zawałem serca leczonych inwazyjnie
  87. Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation
  88. Atrial fibrillation in cardiac resynchronization recipients with and without prior arrhythmic history. How much of arrhythmia is too much?
  89. Can we rely on machines? Device-detected atrial high rates correspond well with atrial arrhythmias in cardiac resynchronization recipients
  90. Quality of Life in Cardiac Resynchronization Recipients: Association with Response and Impact on Outcome
  91. Naprzemienny blok prawej i lewej odnogi pęczka Hisa
  92. Skuteczność terapii resynchronizującej w leczeniu pacjentów ze schyłkową niewydolnością serca zależnych od leków inotropowych
  93. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
  94. Trying to predict the unpredictable: Variations in device-based daily monitored diagnostic parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization therapy
  95. Sleep-disordered breathing and echocardiographic measures of function and dyssynchrony
  96. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm
  97. Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy—incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial
  98. Prognostic significance of HbA1c in patients with AMI treated invasively and newly detected glucose abnormalities
  99. Catheter ablation of atrial fibrillation: current status, techniques, outcomes and challenges
  100. The incidence and risk factors of stroke in patients with acute myocardial infarction treated invasively and concomitant impaired renal function
  101. Migotanie przedsionków u chorej z utajonym zespołem Wolffa-Parkinsona-White’a
  102. Is it important to monitor the percentage of cardiac resynchronization day by day?
  103. The risk of contrast-induced nephropathy and its prognostic significance in patients with different glucose abnormalities and acute myocardial infarction treated invasively
  104. Trying to predict the unpredictable:device-based daily monitored parameters can predict malignant arrhythmic events in patients undergoing cardiac resynchronization
  105. Lack of improvement in quality of life after cardiac resynchronization therapy is a potent determinant of unfavorable outcomes independently from functional and echocardiographic response
  106. Atrial fibrillation types predict the development of contrast-induced nephropathy in patients with acute myocardial infarction treated invasively
  107. The incidence, clinical significance of depression and changes in its clinical course after a cardiac device implantation in patients with congestive heart failure
  108. Upgrade of implantable cardioverter-defibrillator to Cardiac Resynchronization Therapy with Defibrillator (CRT-D). In which patients shall we expect?
  109. Wielopunktowa stymulacja dwukomorowa w terapii resynchronizującej serce
  110. Many response criteria are poor predictors of outcomes after cardiac resynchronization therapy: validation using data from the randomized trial
  111. Burza elektryczna w erze pacjentów z kardiowerterem-defibrylatorem
  112. Pacemaker endocarditis – did we let the genie out of the bottle? Comment on "Implantation of an epicardial lead through mini-thoracotomy as an alternative for patients with lead-related endocarditis who require permanent pacing"
  113. Effect of Type of Atrial Fibrillation on Prognosis in Acute Myocardial Infarction Treated Invasively
  114. Implantation Feasibility, Procedure-Related Adverse Events and Lead Performance During 1-Year Follow-Up in Patients Undergoing Triple-Site Cardiac Resynchronization Therapy: A Substudy of TRUST CRT Randomized Trial
  115. The risk of stroke in patients with acute myocardial infarction treated invasively
  116. The prognostic value of different glucose abnormalities in patients with acute myocardial infarction treated invasively
  117. Effect of Cardiac Resynchronization on Gradient Reduction in Patients with Obstructive Hypertrophic Cardiomyopathy: Preliminary Study
  118. The impact of unsuccessful percutaneous coronary intervention on short- and long-term prognosis in STEMI and NSTEMI
  119. The Incremental Value of Right Ventricular Indices for Predicting Response to Cardiac Resynchronization Therapy
  120. Assessment of apical rocking: a new, integrative approach for selection of candidates for cardiac resynchronization therapy
  121. Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators
  122. Effect of Anemia in High-Risk Groups of Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
  123. Transseptal versus transaortic approach for radiofrequency ablation in patients with cardioverter–defibrillator and electrical storm
  124. Prognostic Significance of Hyperuricemia in Patients with Different Types of Renal Dysfunction and Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention
  125. Triple-Site Versus Standard Cardiac Resynchronization Therapy Study (TRUST CRT): Clinical Rationale, Design, and Implementation
  126. Effects of Cardiac Resynchronization Therapy on Heart Rate Turbulence
  127. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: A preliminary study
  128. Premature Complexes, Atrial and Ventricular
  129. Sleep apnoea as a predictor of mid- and long-term outcome in patients undergoing cardiac resynchronization therapy
  130. Evaluation of left ventricular systolic and diastolic function in patients with atrioventricular re-entrant tachycardia treated by radiofrequency current ablation
  131. Doppler predictors of inducibility of atrial fibrillation in patients with WPW syndrome and atrioventricular re-entrant tachycardia
  132. Sequence of electrical activation, atrial remodelling and atrial fibrillation in patients with nodal re-entrant tachycardia
  133. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study
  134. Resynchronization or Dyssynchronization?Successful Treatment with Biventricular Stimulation of a Child with Obstructive Hypertrophic Cardiomyopathy without Dyssynchrony
  135. Triple site biventricular pacing in a patient with congestive heart failure and severe mechanical dyssynchrony
  136. Different Types of Renal Dysfunction in Patients with Acute Myocardial Infarction Treated with Percutaneous Coronary Intervention
  137. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention
  138. Influence of Reciprocating Tachycardia on the Development of Atrial Fibrillation in Patients with Preexcitation Syndrome
  139. 172 Sleep apnea in patients with cardiac resynchronization therapy - what role plays an echocardiography: background, equal or just a helping hand?
  140. 394 The influence of cardiac resynchronization therapy on right ventricular systolic function in heart failure patients with right ventricular impairment
  141. Effect of Percutaneous Interventions within the Coronary Sinus on the Success Rate of the Implantations of Resynchronization Pacemakers
  142. Coronary sinus stenting for the stabilization of left ventricular lead during resynchronization therapy
  143. A37-4 Surface ECG can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia
  144. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy
  145. P-089 Radiofrequency catheter ablation in patients with congenital heart disease
  146. P-164 Trend of heart rate variability in patients treated with cardiac resynchronization therapy
  147. P-043 The evaluation of paroxysmal atrial fibrillation using event holter loop recording
  148. A05-2 Atrial pressures during reciprocating tachycardia as a risk factor for atrial fibrillation in WPW-patients
  149. A24-2 Atrial conduction velocity is a marker of atriomyopathy progression in patients with atrial flutter
  150. A37-4 Surface ecg can predict peri-hisian localization of ectopic focus in patients undergoing radiofrequency ablation of idiopatic right ventricular arrhythmia
  151. P-266 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy
  152. Electrophysiological Features of Orthodromic Atrioventricular Reentry Tachycardia in Patients with Wolff-Parkinson-White Syndrome and Atrial Fibrillation
  153. P354 Sequence of atrio-ventricular electrical excitation during nodal reentry tachycardia influences the development of atriomyopathy